By proceeding, you agree to our Terms of Use and Privacy Policy.
Experienced large molecule oncology drug developer. Skilled in building and leading teams to deliver from target identification through to IND and clinical development. Strong understanding of translational research needed to define patient segments and clincal development plans for novel drugs. Experience in developing antagonistic/agonistic antibodies, immuno-oncology drugs and antibody drug conjugates. Well-published, strong scientist with greater than 60 publications and 11,000 citations.
Talks About #clinical #drugtranslational
Preferred Locations #NorthAmerica
3 years since we last brought the community together in-person in San Diego we are excited to once more unite 600+ ADC enthusiasts at the World’s Definitive Antibody-Drug Conjugate Event.
